Showing results (201-210 of 216) with videos related to

Sort By:
Pageof 22
Anticancer Research|February 2, 2024
CRP-albumin-lymphocyte (CALLY) Index Is an Independent Prognostic Factor for the Esophageal Cancer Patients Who Received Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
In Vivo (Athens, Greece)|October 31, 2023
The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
Anticancer Research|February 2, 2024
Comparison of Dietary Intake After Gastric Cancer Gastrectomy Between Patients With and Without Postoperative Surgical ComplicationsMie Tanabe, Toru Aoyama, Masato Nakazono, et al.
European Journal of Haematology|May 27, 2025
Site- and Stage-Adapted Treatment Strategies for Gastrointestinal Diffuse Large B-Cell LymphomaYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.
Anticancer Research|December 30, 2023
Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative TreatmentToru Aoyama, Aya Kato, Itaru Hashimoto, et al.
Journal of Cancer Research and Clinical Oncology|November 23, 2019
High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1Yukio Maezawa, Kentaro Sakamaki, Naohide Oue, et al.
Anticancer Research|November 1, 2023
The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative SurgeryToru Aoyama, Itaru Hashimoto, Yukio Maezawa, et al.
In Vivo (Athens, Greece)|February 28, 2024
The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative TreatmentToru Aoyama, Aya Kato, Itaru Hashimoto, et al.
Anticancer Research|November 29, 2023
The Clinical Influence of Geriatric Nutritional Risk Index in Patients With Gastric Cancer Who Receive Curative TreatmentToru Aoyama, Yukio Maezawa, Itaru Hashimoto, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 23, 2023
Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomachSeong-Ho Kong, Yukinori Kurokawa, Jeong-Hwan Yook, et al.
Pageof 22